DOWNERS GROVE, Ill. – June 23, 2015 – Univar Inc. (NYSE: UNVR) (the “Company”), a global chemical distributor and provider of value-added services, announced today the closing of its previously announced initial public offering of common stock at a price of $22.00 per share. The Company’s common stock began trading June 18 on the New York Stock Exchange under the ticker symbol UNVR.
The underwriters for the initial public offering exercised in full their option to purchase from certain of our stockholders an additional 5,250,000 shares of common stock. As a result, 20,000,000 shares of common stock were sold by the Company and 20,250,000 shares of common stock were sold by certain of our stockholders in the initial public offering. In addition, the Company completed a concurrent private placement of $350 million of shares of common stock to Dahlia Investments Pte. Ltd., an indirect wholly owned subsidiary of Temasek Holdings (Private) Limited.
Deutsche Bank Securities, Goldman, Sachs & Co., and BofA Merrill Lynch acted as joint book-running managers. Additional book-running managers were Barclays Capital Inc., Credit Suisse Securities (USA) LLC, J.P. Morgan Securities LLC, Jefferies LLC, and Morgan Stanley & Co. LLC.
Copies of the prospectus relating to the offering may be obtained from:
Deutsche Bank Securities Inc., Attention: Prospectus Group, 60 Wall Street, New York, NY 10005-2836, by email to
[email protected], or by telephone at (800) 503-4611.
Goldman, Sachs & Co., Attention: Prospectus Department, 200 West Street, New York, NY 10282, by email to
[email protected], by telephone at (866) 471-2526, or by fax at (212) 902-9316.
A registration statement relating to these securities has been filed with, and declared effective by, the U.S. Securities and Exchange Commission (SEC). This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these shares in any state in which such offer, solicitation or sale would be unlawful, prior to registration or qualification under the securities laws of any state.
###
About Univar
Founded in 1924, Univar is a global distributor of specialty and basic chemicals from more than 8,000 producers worldwide. Univar operates more than 700 distribution facilities throughout North America, Western Europe, the Asia-Pacific region, and Latin America, supported by a global network of sales and technical professionals. With a broad portfolio of products and value-added services, and deep technical and market expertise, Univar delivers the tailored solutions customers need through one of the most extensive chemical distribution networks in the world. Univar is Chemistry Delivered
SM.
Forward-Looking Statements
This press release includes “forward-looking statements,” including with respect to the proposed initial public offering, within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond our control. We caution you that the forward-looking information presented in this press release is not a guarantee of future events, and that actual events may differ materially from those made in or suggested by the forward-looking information contained in this press release. In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “plan,” “seek,” “comfortable with,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe” or “continue” or the negative thereof or variations thereon or similar terminology. Any forward-looking information presented herein is made only as of the date of this press release, and we do not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise.
FOR ADDITIONAL INFORMATION
Investor Relations:
Kerri Howard
+1 844-632-1060
[email protected]
Media Relations:
Scott C. Johnson
+1 331-777-6187
[email protected]
